MedPath

Efficacy of Manual Therapy in Migraine

Not Applicable
Completed
Conditions
MIGRAINE
Interventions
Other: Trapezius MTRP and stretching
Other: Sternocleidomastoid MTRP and stretching
Registration Number
NCT02446275
Lead Sponsor
University of Valencia
Brief Summary

Objective: The aim of this study was to determine the efficacy of suboccipital inhibitory manual therapy treatment in migraine compared to treatment based on Myofascial Trigger Points (MTrPs) and their stretching, often being hypersensitive in patients with migraine.

Material and methods: 27 patients in two groups participated in the study: a) the control group received combined techniques based on MTrPs and bilateral stretching in the trapezius and sternocleidomastoid muscle (SCM); b) the experimental group was applied the same techniques as those applied in the control group plus suboccipital inhibition. The treatment lasted for 8 weeks and the impact, disability and quality of life were assessed in both groups.

Detailed Description

Introduction Migraine is a highly prevalent disorder entailing substantial costs. Manual therapy offers an attractive option as an alternative to medical treatment or used in combination therewith. Treatment focused on the soft tissues of the suboccitpital region has been studied in other types of headaches but not in migraine.

Objective: The aim of this study was to determine the efficacy of suboccipital inhibitory manual therapy treatment in migraine compared to treatment based on Myofascial Trigger Points (MTrPs) and their stretching, often being hypersensitive in patients with migraine.

Material and methods: 27 patients in two groups participated in the study: a) the control group received combined techniques based on MTrPs and bilateral stretching in the trapezius and sternocleidomastoid muscle (SCM); b) the experimental group was applied the same techniques as those applied in the control group plus suboccipital inhibition. The treatment lasted for 8 weeks and the impact, disability and quality of life were assessed in both groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients were diagnosed according to the criteria established by the IHS
Exclusion Criteria
  • Patients were excluded if they presented with other headache types, if their headache was triggered by neck movement, or if they presented with dizziness, hypertension, emotional stress, psychological disorders, cardiovascular disease or pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sternocleidomastoid MTRP and stretchingTrapezius MTRP and stretchingThe sternocleidomastoid was treated with ischemic compression.
Trapezius MTRP and stretchingSternocleidomastoid MTRP and stretchingThe central MTRP of the trapezius was treated as described above for the sternocleidomastoid.
Primary Outcome Measures
NameTimeMethod
Pain intensity4 weeks

The Visual Analogue Scale (VAS)25 was used to rate the patients average pain intensity using a 0-10 scale (0=no pain, 10=the most severe pain).

Secondary Outcome Measures
NameTimeMethod
Disability (MIDAS)4 weeks

. Disability caused by migraine was assessed by the MIDAS questionnaire (Adenis Silva et al., 2008) based on 5 questions and the score obtained from the sum of the days lost due to headaches registered in the questions.

The impact of headache (HIT-6)4 weeks

The Headache Impact Test (HIT-6) (Yang et al., 2011) provides an overall measure of the adverse impact of headaches. This questionnaire consists of 6 items measuring the impact of pain on social functioning, role functioning, vitality, cognitive functioning and psychological distress, and provides a measure of the severity.

Trial Locations

Locations (1)

Gemma v. Espí López

🇪🇸

Valencia, Spain

© Copyright 2025. All Rights Reserved by MedPath